Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.22.2.2
Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Statements of Operations        
Grant revenue $ 50,978 $ 84,705 $ 175,986 $ 326,766
Cost of grant revenue 50,978 84,705 175,986 326,766
Gross profit 0 0 0 0
Operating expenses:        
Research and development 728,383 560,693 1,556,930 821,573
General and administrative 734,637 603,518 1,587,586 1,204,204
Sales and marketing 233,152 112,033 452,581 174,611
Total operating expenses 1,696,172 1,276,244 3,597,097 2,200,388
Loss from operations (1,696,172) (1,276,244) (3,597,097) (2,200,388)
Other income:        
Interest income (expense), net 6,178 (1,856) 2,462 (1,862)
Gain on forgiveness of long-term debt   91,407 0 91,407
Total other income 6,178 89,551 2,462 89,545
Net loss $ (1,689,994) $ (1,186,693) $ (3,594,635) $ (2,110,843)
Net loss per share - basic $ (0.27) $ (0.19) $ (0.58) $ (0.37)
Net loss per share - diluted $ (0.27) $ (0.19) $ (0.58) $ (0.37)
Weighted average number of shares outstanding - basic 6,157,625 6,125,874 6,156,495 5,737,109
Weighted average number of shares outstanding - diluted 6,157,625 6,125,874 6,156,495 5,737,109